Abstract
The objective of the present study was to investigate the in vitro effects of the branched-chain α-keto acids accumulating in maple syrup urine disease, namely L-2-ketoisocaproic acid, L-2-keto-3-methylvaleric acid and L-2-ketoisovaleric acid on Na+, K+-ATPase activity in synaptic plasma membranes from cerebral cortex of 35-day-old rats. All keto acids significantly inhibited Na+, K+-ATPase activity at concentrations similar (1 mM) or even lower (0.5 mM) than those found in blood and cerebrospinal fluid of maple syrup urine disease patients. We also tested the effects of alanine on this enzyme activity. Alanine per se did not alter Na+, K+-ATPase activity, but totally prevented the branched-chain α-keto acids-induced Na+, K+-ATPase inhibition, indicating that alanine and the keto acids may possibly bind to the same site on the enzyme. We also observed that the branched-chain amino acids leucine, isoleucine and valine also inhibited Na+ K+-ATPase activity to a similar degree as that of the branched-chain α-keto acids and that alanine was able to fully prevent these effects. Considering that Na+, K+-ATPase is a critical enzyme for normal brain development and functioning, it is presumed that these findings may be involved in the pathophysiology of the neurological dysfunction of maple syrup urine disease.
Similar content being viewed by others
References
Araujo P, Wassermann GF, Tallini K, Furlanetto V, Vargas CR, Wannmacher CM, Dutra-Filho CS, Wyse AT, Wajner M (2001) Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. Neurochem Int 38:529–537
Bavaresco CS, Zugno AI, Tagliari B, Wannmacher CMD, Wajner M, Wyse ATS (2004) Inhibition of Na+, K+-ATPase activity in rat striatum by the metabolites accumulated in Lesch-Nyhan disease. Int J Devel Neurosci 22:11–17
Ben-Ari Y (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14:375–403
Bridi R, Araldi J, Sgarbi MB, Testa CG, Durigon K, Wajner M, Dutra-Filho CS (2003) Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int J Dev Neurosci 21:327–332
Bridi R, Braun CA, Zorzi GK, Wannmacher CM, Wajner M, Lissi EG, Dutra-Filho CS (2005) Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defenses in cerebral cortex from young rats. Metab Brain Dis 20:155–167
Bridi R, Latini A, Braum CA, Zorzi GK, Wajner M, Lissi E, Dutra-Filho CS (2005a) Evaluation of the mechanisms involved in leucine-induced oxidative damage in cerebral cortex of young rats. Free Radic Res 39:71–79
Chan KM, Delfert D, Junger KD (1986) A direct colorimetric assay for Ca2+-stimulated ATPase activity. Anal Biochem 157:375–380
Choi DW, Rothman SM (1990) The role of glutamate neurotoxicity in hypoxicischemic neuronal death. Ann Rev Neurosci 13:171–182
Chuang DT, Shih VE (2001) Maple syrup urine disease (branched-chain ketoaciduria). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. Ma Graw-Hill, New York, pp 1971–2005
Coitinho AS, de Mello CF, Lima TT, de Bastiani J, Fighera MR, Wajner M (2001) Pharmacological evidence that alpha-ketoisovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats. Brain Res 894:68–73
Cousin MA, Nicholls DG, Pocock JM (1995) Modulation of ion gradients and glutamate release in cultured cerebellar granule cells by ouabain. J Neurochem 64:2097–2104
de Castro Vasques V, Boer MA, Diligenti F, Brinco F, Mallman F, Mello CF, Wajner M (2004) Intrahippocampal administration of the α-keto acids accumulating in maple syrup urine disease provokes learning deficits in rats. Pharmacol Biochem Behav 77:183–190
Dodd PR, Williams SH, Gundlach AL, Harper PA, Healy PJ, Dennis JA, Johnston GA (1992) Glutamate and gama-aminobutyric acid neurotransmitter systems in the acute phase of maple syrup urine disease and citrullinemia encephalopathies in newborn calves. J Neurochem 59:582–590
Erecinska M, Silver IA (1994) Ions and energy in mammalian brain. Prog Neurobiol 43:37–71
Fontella FU, Gassen E, Pulronik V, Wannmacher CM, Klein AB, Wajner M, Dutra-Filho CS (2002) Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab Brain Dis 17:47–54
Fontella FU, Pulrolnik V, Gassen E, Wannmacher CM, Klein AB, Wajner M, Dutra-Filho CS (2000) Propionic and L-methylmalonic acids induce oxidative stress in brain of young rats. Neuroreport 11:541–544
Geering K (1990) Subunit assembly and functional maturation of Na+, K(+)-ATPase. J Membrane Biol 115:109–121
Grisar T (1984) Glial and neuronal Na+, K+-ATPase pump in epilepsy. Ann Neurol 16:128–134
Halestrap AP, Brand MD, Denton RM (1974) Inhibition of mitochondrial piruvate transport by phenylpyruvate and α-ketoisocaproate. Biochim Biophys Acta 367:102–108
Henver RF, Duff RS, Wong-Ryley MTT (1992) Coordination of ATP production and consumption in brain: parallel regulation of cytochrome oxidase and Na+, K+-ATPase. Neurosci Lett 138:188–192
Hilliges C, Awiszus D, Wendel U (1993) Intellectual performance of children with maple syrup urine disease. Eur J Pediatr 152:144–147
Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL (1993) Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis 16:648–669
Howell RK, Lee M (1963) Influence of α-keto acids on the respiration of brain in vitro. Proc Soc Exp Biol Med 113:660–663
Jones DH, Matus AI (1974) Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation. Biochim Biophys Acta 356:276–287
Jouvet P, Rustin P, Taylor DL, Pocock JM, Felderhoff-Mueser U, Mazarakis ND, Sarraf C, Joashi U, Kozma M, Greenwood K, Edwards AD, Mehmet H (2000) Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol Biol Cell 1:1919–1932
Kolker S, Okun JG, Ahlemeyer B, Wyse AT, Horster F, Wajner M, Kohlmuller D, Mayatepek E, Kriglstein J, Hoffmann GF (2002) Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons. J Neurosci Res 68:424–431
Kurella E, Kukley M, Tyulina O, Dobrota D, Matejovicova M, Mezesova V, Boldyrev A (1997) Kinetic parameters of Na/K-ATPase modified by free radicals in vitro and in vivo. Ann NY Acad Sci 834:661–665
Land JM, Mowbray J, Clark JB (1976) Control of pyruvate and β-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease. J Neurochem 26:823–830
Lees GJ (1993) Contributory mechanisms in the causation of neurodegenerative disorders. Neuroscience 54:287–322
Lees GJ (1991) Inhibition of sodium-potassium-ATPase: a potential ubiquitous mechanism contributing to central nevous system neuropathology. Brain Res Rev 16:283–300
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275
Naughten ER, Jenkings J, Francis DE, Leonard JV (1982) Outcome of maple syrup utine disease. Arch Dis Child 57:918–921
Oldendorf WH (1973) Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol 224:1450–1453
Pilla C, Cardozo RF, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2003) Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro. Neurochem Res 28:675–679
Pilla C, Cardozo RF, Dutra-Filho CS, Wyse AT, Wajner M, Wannmacher CM (2003) Effect of leucine administration on creatine kinase activity in rat brain. Metab Brain Dis 18:17–25
Prensky AL, Moser HW (1967) Changes in the amino acid composition of proteolipids of white matter during maturation of the human nervous system. J Neurochem 14:117–121
Renkawek K, Renier WO, De Pont JJ, Vogels OJ, Gabreels FJ (1992) Neonatal status convulsivus, spongiform encephalopathy, and low activity of Na+/K(+)-ATPase in the brain. Epilepsy 33:58–64
Rousson R, Guibaud P (1984) Long term outcome of organic acidurias: survey of 105 French cases (1967–1983). J Inherit Metab Dis 7(Suppl 1):10–12
Satoh E, Nakasato Y (1992) On the mechanism of ouabain-induced released of acetylcholine from synaptosomes. J Neurochem 58:1038–1044
Schonberger S, Schweiger B, Schwahn B, Schwarz M, Wendel U (2004) Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol Genet Metab 82:69–75
Sgaravatti AM, Rosa RB, Schuck PF, Ribeiro CA, Wannmacher CM, Wyse AT, Dutra-Filho CS, Wajner M (2003) Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease. Biochim Biophys Acta 1639:232–238
Snyderman SE, Goldstein F, Sansaricq C, Norton PM (1984) The relationship between the branched chain amino acids and their α-ketoacids in maple syrup urine disease. Pediatr Res 18:851–853
Snyderman SE, Morton PM, Roitman E, Holt LE Jr (1964) Maple syrup urine disease with a particular reference to diet therapy. Pediatrics 34:454–472
Steele RD (1986) Blood-brain barrier transport of the alpha-keto acid analogs of amino acids. Fed Proc 45:2060–2064
Streck EL, Zugno AI, Tagliari B, Wannmacher CMD, Wajner M, Wyse ATS (2002) Inhibition of Na+-K+-ATPase activity by the metabolites accumulating in homocystinuria. Metab Brain Dis 17:83–91
Tavares RG, Santos CE, Tasca CI, Wajner M, Souza DO, Dutra-Filho CS (2001) Inhibition of glutamate uptake into synaptic vesicles from rat brain by 3-nitropropionic acid in vitro. Exp Neurol 172:250–254
Tsakiris S, Deliconstantinos G (1984) Influence of phosphatidylserine on (Na+ K+)-stimulated ATPase and acethylcholinesterase activities of dog brain synaptosomal plasma membranes. Biochem J 22:301–307
Wang XQ, Xiao AY, Sheline C, Hyrc K, Yang A, Goldberg MP, Choi DW, Yu SP (2003) Apoptotic insults impair Na+, K+-ATPase activity as a mechanism of neuronal death mediated by concurrent ATP deficiency and oxidant stress. J Cell Sci 116:2099–2110
Wyse AT, Brusque AM, Silva CG, Streck EL, Wajner M, Wannmacher CM (1998) Inhibition of Na+, K+-ATPase from rat brain cortex by propionic acid. Neuroreport 9:1719–1721
Wyse AT, Noriler ME, Borges LF, Floriano PJ, Silva CG, Wajner M, Wannmacher CM (1999) Alanine prevents the decrease of Na+, K+ -ATPase activity in experimental phenylketonuria. Metab Brain Dis 14:95–101
Wyse AT, Wajner M, Brusque A, Wannmacher CM (1995) Alanine reverses the inhibitory effect of phenylalanine and its metabolites on Na+, K(+)-ATPase in synaptic plasma membranes from cerebral cortex of rats. Biochem Soc Trans 23:227S
Wyse ATS, Streck EL, Worm P, Wajner A, Ritter F, Netto CA (2000) Preconditioning prevents the inhibition of Na+, K+-ATPase activity after brain ischemia. Neurochem Res 25:969–973
Wyse ATS, Wajner M, Wannmacher CMD (1998) Kinects of alanine reversal on the inhibition of Na+, K+-ATPase activity by phenylalanine and phenillactate in the synaptic plasma membrane from the cerebral cortex of rats. Med Sci Res 26:141–143
Xiao AY, Wei L, Xia S, Rothman S, Yu SP (2002) Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J Neurosci 22:1350–1362
Yang YB, Piao YJ (2003) Effects of resveratrol on secondary damages after acute spinal cord injury in rats. Acta Pharmacol 24:703–710
Yousef MI, El-Hendy HA, El-Demerdash FM, Elagamy EI (2002) Dietary zinc deficiency induced-changes in the activity of enzymes and the levels of free radicals, lipids and protein electrophoretic behavior in growing rats. Toxicology 175:223–234
Yu SP (2003) Na+, K+-ATPase: the new face of an old player in pathogenesis and apoptotic/hybrid cell death Biochem. Pharmacol 66:1601–1609
Yudkoff M, Daikhim Y, Lin ZP, Nissim I, Sterm J, Pleasure D (1994) Interrelationships of leucine and glutamate metabolism in cultures astrocytes. J Neurochem 62:1191–1192
Zielke HR, Zielke CL, Baab PJ, Collins RM (2002) Large neutral amino acids auto exchange when infused by microdialysis into the rat brain: implications for maple syrup urine disease and phenylketonuria. Neurochem Int 40:347–354
Acknowledgments
This work was supported in part by grants from Conselho Nacional de Desenvolvimento Científico e tecnológico (CNPq-Brazil), Fundação de Amparo à Pesquisa do Rio Grande do Sul (FAPERGS, RS-Brazil) and Programa de Núcleos de Excelência-Financiadora de Estudos e Projetos (PRONEX II, FINEP-CNPq-Brazil).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wajner, A., Bürger, C., Dutra-Filho, C.S. et al. Synaptic Plasma Membrane Na+, K+-ATPase Activity is Significantly Reduced by the α-Keto Acids Accumulating in Maple Syrup Urine Disease in Rat Cerebral Cortex. Metab Brain Dis 22, 77–88 (2007). https://doi.org/10.1007/s11011-007-9046-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-007-9046-5